144 related articles for article (PubMed ID: 23488775)
1. Therapeutic implications of endothelin and thrombin G-protein-coupled receptor transactivation of tyrosine and serine/threonine kinase cell surface receptors.
Kamato D; Burch ML; Osman N; Zheng W; Little PJ
J Pharm Pharmacol; 2013 Apr; 65(4):465-73. PubMed ID: 23488775
[TBL] [Abstract][Full Text] [Related]
2. GPCR responses in vascular smooth muscle can occur predominantly through dual transactivation of kinase receptors and not classical Gαq protein signalling pathways.
Little PJ
Life Sci; 2013 May; 92(20-21):951-6. PubMed ID: 23583575
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor.
Little PJ; Burch ML; Getachew R; Al-aryahi S; Osman N
J Cardiovasc Pharmacol; 2010 Oct; 56(4):360-8. PubMed ID: 20625315
[TBL] [Abstract][Full Text] [Related]
4. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.
Burch ML; Ballinger ML; Yang SNY; Getachew R; Itman C; Loveland K; Osman N; Little PJ
J Biol Chem; 2010 Aug; 285(35):26798-26805. PubMed ID: 20571025
[TBL] [Abstract][Full Text] [Related]
5. Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes.
Kamato D; Thach L; Getachew R; Burch M; Hollenberg MD; Zheng W; Little PJ; Osman N
Cell Signal; 2016 Jan; 28(1):110-9. PubMed ID: 26548632
[TBL] [Abstract][Full Text] [Related]
6. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells.
Kamato D; Bhaskarala VV; Mantri N; Oh TG; Ling D; Janke R; Zheng W; Little PJ; Osman N
PLoS One; 2017; 12(7):e0180842. PubMed ID: 28719611
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor transactivation in vascular smooth muscle cells.
Burch ML; Getachew R; Osman N; Febbraio MA; Little PJ
J Biol Chem; 2013 Mar; 288(10):7410-9. PubMed ID: 23335513
[TBL] [Abstract][Full Text] [Related]
9. The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier.
Kamato D; Rostam MA; Bernard R; Piva TJ; Mantri N; Guidone D; Zheng W; Osman N; Little PJ
Cell Mol Life Sci; 2015 Feb; 72(4):799-808. PubMed ID: 25384733
[TBL] [Abstract][Full Text] [Related]
10. The endothelin system and endothelin receptor antagonists.
Jandeleit-Dahm KA; Watson AM
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):66-71. PubMed ID: 22123210
[TBL] [Abstract][Full Text] [Related]
11. Cell-surface receptors transactivation mediated by g protein-coupled receptors.
Cattaneo F; Guerra G; Parisi M; De Marinis M; Tafuri D; Cinelli M; Ammendola R
Int J Mol Sci; 2014 Oct; 15(11):19700-28. PubMed ID: 25356505
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease.
Force T; Kuida K; Namchuk M; Parang K; Kyriakis JM
Circulation; 2004 Mar; 109(10):1196-205. PubMed ID: 15023894
[TBL] [Abstract][Full Text] [Related]
13. Thrombin receptor antagonists as novel therapeutic targets.
Chackalamannil S
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):417-27. PubMed ID: 11727307
[TBL] [Abstract][Full Text] [Related]
14. The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction.
Waters C; Pyne S; Pyne NJ
Semin Cell Dev Biol; 2004 Jun; 15(3):309-23. PubMed ID: 15125894
[TBL] [Abstract][Full Text] [Related]
15. Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells.
Rauch BH; Millette E; Kenagy RD; Daum G; Clowes AW
Circ Res; 2004 Feb; 94(3):340-5. PubMed ID: 14670838
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow?
Pyne NJ; Pyne S
Trends Pharmacol Sci; 2011 Aug; 32(8):443-50. PubMed ID: 21612832
[TBL] [Abstract][Full Text] [Related]
17. GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species.
Mohamed R; Janke R; Guo W; Cao Y; Zhou Y; Zheng W; Babaahmadi-Rezaei H; Xu S; Kamato D; Little PJ
Vasc Biol; 2019; 1(1):R1-R11. PubMed ID: 32923966
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases.
Natarajan K; Berk BC
Methods Mol Biol; 2006; 332():51-77. PubMed ID: 16878685
[TBL] [Abstract][Full Text] [Related]
19. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
20. G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors.
Burch ML; Osman N; Getachew R; Al-Aryahi S; Poronnik P; Zheng W; Hill MA; Little PJ
Int J Biochem Cell Biol; 2012 May; 44(5):722-7. PubMed ID: 22326998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
